Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.080
+0.080 (4.00%)
At close: Oct 15, 2026, 4:00 PM EDT
2.120
+0.040 (1.92%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Compugen Market Cap
Compugen has a market cap or net worth of $197.03 million as of October 15, 2026. It is the 20,886th most valuable company in the world and the 3,603rd biggest in the United States. Its market cap has decreased by 0.19% in one year.
Market Cap
197.03M
Enterprise Value
74.75M
1-Year Change
-0.19%
Global Rank
Country Rank
#3,603 United States
Category
ChartMarket Cap Chart
Since December 31, 2002, Compugen's market cap has increased from $46.50M to $197.03M, an increase of 323.71%. That is a compound annual growth rate of 6.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 197.00M | 37.67% |
| Dec 31, 2025 | 143.10M | 4.45% |
| Dec 31, 2024 | 137.00M | -21.58% |
| Dec 29, 2023 | 174.70M | 181.77% |
| Dec 30, 2022 | 62.00M | -82.82% |
| Dec 31, 2021 | 360.80M | -64.38% |
| Dec 31, 2020 | 1.01B | 183.96% |
| Dec 31, 2019 | 356.70M | 220.49% |
| Dec 31, 2018 | 111.30M | -12.91% |
| Dec 29, 2017 | 127.80M | -50.45% |
| Dec 30, 2016 | 257.90M | -19.68% |
| Dec 31, 2015 | 321.10M | -5.97% |
| Dec 31, 2014 | 341.50M | 4.27% |
| Dec 31, 2013 | 327.50M | 91.74% |
| Dec 31, 2012 | 170.80M | 1.73% |
| Dec 30, 2011 | 167.90M | 3.83% |
| Dec 31, 2010 | 161.70M | 16.92% |
| Dec 31, 2009 | 138.30M | 1,033.61% |
| Dec 31, 2008 | 12.20M | -72.95% |
| Dec 31, 2007 | 45.10M | -37.45% |
| Dec 29, 2006 | 72.10M | -38.95% |
| Dec 30, 2005 | 118.10M | -14.61% |
| Dec 31, 2004 | 138.30M | 4.38% |
| Dec 31, 2003 | 132.50M | 184.95% |
| Dec 31, 2002 | 46.50M | - |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 216.33M |
| Evommune | 214.49M |
| MacroGenics | 212.12M |
| ProQR Therapeutics | 208.86M |
| Cartesian Therapeutics | 200.90M |
| Invivyd | 197.46M |
| Lyell Immunopharma | 193.84M |
| Alpha Cognition | 190.45M |